SEC Form D · filed April 9, 2020
CRISPR Therapeutics AG
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (32)
Ali Behbahani · Zug, V8DirectorD. A. Tatman Ii · NASHVILLE, TNExecTony Ho · Zug, V8ExecChristian Klacko · Boston, MAExec · DirectorRodger Novak · Basel, V8Exec · DirectorJohn Reeves · Sheridan, WYDirectorTrinda A. Blackmore · Grand Cayman, Cayman IslandsDirectorScott Shipman · Vancouver, British Columbia, CanadaExecKatherine High · Zug, V8DirectorMichael Tomsicek · Zug, V8ExecBurke Wise · NEW YORK, NYDirectorNolan T. Altman · Oceanside Drive, NYDirectorSimeon George · Zug, V8DirectorBradley Bolzon · Zug, V8DirectorHenry Russell · Sheridan, WYExecJohn Greene · Zug, V8DirectorSebastian Caliri · AUSTIN, TXDirectorLynne Winings · Cleveland, OHDirectorJustin Butler · San Francisco, CADirectorSamarth Kulkarni · Zug, V8Exec · DirectorElisa Zhang · Cedar City, UTDirectorFoy H. Tatum · Montgomery, ALExecLawrence Klein · Zug, V8ExecJustin C. Valley · Lake Oswego, ORExecJames Kasinger · Zug, V8ExecDan Bergrin · Cleveland, OHDirectorTerry Wheeler · ROSEVILLE, CAExecAdy N. Adefris · Quarry Bay, Hong KongExec · DirectorRodger Novak · Basel, V8Exec · DirectorYing Wang · Mountain View, CAExecIan Sheridan · Boston, MAExecAlexander Harrington · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗